daclizumab
Ligand Summary
An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.
ChEMBL: CHEMBL1201605
DrugCentral: 4953
LyCHI: daclizumab
Target Activities
3 Activities
Items per page:
10
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Kd | ANTIBODY BINDING | |||||
Kd | ANTIBODY BINDING | |||||
Kd | ANTIBODY BINDING | |||||